secwatch / observer
8-K filed March 14, 2024, 7:59 PM ET ticker VTVT CIK 0001641489
leadership confidence high sentiment neutral materiality 0.40

vTv Therapeutics elects Anne Phillips as director; Fry and Weiner resign

vTv Therapeutics Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anne Phillips

director
VTVT · vTv Therapeutics Inc.
Effective
2024-03-13
Filed
March 14, 2024, 7:59 PM ET
On March 12, 2024, Anne Phillips was elected as director of vTv Therapeutics, Inc. (the “Company”), effective and contingent on the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which occurred on March 13, 2024 (the “2023 Annual Report”).
Departed

Howard Weiner

director
VTVT · vTv Therapeutics Inc.
Effective
2024-03-13
Filed
March 14, 2024, 7:59 PM ET
John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.
Departed

John Fry

director
VTVT · vTv Therapeutics Inc.
Effective
2024-03-13
Filed
March 14, 2024, 7:59 PM ET
John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anne Phillips was elected as director at vTv Therapeutics Inc..

Action
elected
Role
director
Exact text from the filing
On March 12, 2024, Anne Phillips was elected as director of vTv Therapeutics, Inc. (the “Company”), effective and contingent on the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which occurred on March 13, 2024 (the “2023 Annual Report”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Howard Weiner resigned as director at vTv Therapeutics Inc..

Action
resigned
Role
director
Exact text from the filing
John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Fry resigned as director at vTv Therapeutics Inc..

Action
resigned
Role
director
Exact text from the filing
John Fry and Howard Weiner resigned from their director roles effective upon the filing of the 2023 Annual Report.
View on SEC.gov

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001641489-24-000014
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.